N Engl J Med 2019 Aug 8
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
Related Questions
Hb at goal of 9-10
New answer by at Boston University School of Medicine (August 16, 2023)
HbSC disease is the stepchild of sickle hemoglobinopathies with almost no studies of its treatment, so that any recommendation is not data based. One might consider adding cri...